![Donna Best](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Donna Best
Sociétés | Poste | Début | Fin |
---|---|---|---|
Triad Life Sciences, Inc.
![]() Triad Life Sciences, Inc. Medical SpecialtiesHealth Technology Part of Convatec Group Plc, Triad Life Sciences, Inc. is a biotech company based in Memphis, TN. The company is focused on developing and commercializing innovative, efficacious and affordable biomaterials for treating complex surgical and chronic wounds. Triad recently received FDA clearance to market Innovamatrix™, a next-generation extracellular matrix (ECM) wound care device. The company was founded in 2017 by Russell I. Olsen, who has been the CEO since then. Triad Life Sciences was acquired by Convatec Group Plc on March 14, 2022 for $450 million. | Directeur/Membre du Conseil | - | - |
Directeur des opérations | - | - |
Historique de carrière de Donna Best
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Triad Life Sciences, Inc.
![]() Triad Life Sciences, Inc. Medical SpecialtiesHealth Technology Part of Convatec Group Plc, Triad Life Sciences, Inc. is a biotech company based in Memphis, TN. The company is focused on developing and commercializing innovative, efficacious and affordable biomaterials for treating complex surgical and chronic wounds. Triad recently received FDA clearance to market Innovamatrix™, a next-generation extracellular matrix (ECM) wound care device. The company was founded in 2017 by Russell I. Olsen, who has been the CEO since then. Triad Life Sciences was acquired by Convatec Group Plc on March 14, 2022 for $450 million. | Health Technology |
- Bourse
- Insiders
- Donna Best
- Expérience